Analysis Plandai Biotechnology, Inc. (PLPL)
5/28/2024
Analysis of Plandai Biotechnology, Inc. (PLPL)
Plandai Biotechnology, Inc. (PLPL) has shown some volatility in its stock price over the past few days. The RSI indicator has been fluctuating around the 50 level, indicating a balanced market sentiment. The MACD indicator has been relatively stable, with the MACD line hovering around the signal line.The moving averages (SMA, EMA, WMA) have been relatively close to each other, suggesting a lack of strong trend in the stock price movement. However, the price has been mostly trading above the moving averages, indicating some bullish momentum.
Overall, Plandai Biotechnology, Inc. seems to be experiencing some price fluctuations without a clear trend direction. Traders and investors may need to closely monitor the stock for any potential breakout or trend reversal.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
The stock statistics show details such as short ratio, float shares, shares outstanding, and percentages held by insiders and institutions. The company's stock price summary includes beta, moving averages, and the range of the stock price over the past fifty-two weeks.
Valuation metrics reveal information about the company's price-to-earnings ratios, enterprise value, price-to-book ratio, price-to-sales ratio, and market capitalization.
Lastly, the dividends and splits data includes details about dividend rates, dividend yields, payout ratio, dividend dates, and historical stock splits.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trajectory.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA increasing from $81 billion in 2020 to $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been able to control its operating expenses effectively, allowing for growth in operating income.
9. Non-operating interest expenses have been managed efficiently, with a slight decrease over the years.
10. The number of basic and diluted shares outstanding has remained relatively stable over the years.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to finance its operations over the years.
7. There is a need to monitor and manage current liabilities effectively to ensure financial stability.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. The company has been generating positive net income each year.
8. Depreciation and stock-based compensation are significant non-cash items affecting the cash flow.
9. The company's cash flow statement reflects a mix of operational, financing, and investing activities that impact its overall financial health.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, compared to $1.26 a year ago. The range of estimates is between $1.27 and $1.36, with 26 analysts providing forecasts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, lower than the $1.46 EPS from the same period last year. The estimates range from $1.44 to $1.63, with 25 analysts contributing to the forecasts.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, up from $6.13 in the previous year. The EPS estimates range from $6.43 to $6.92, with 39 analysts providing their predictions.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to $6.59 in the previous year. The EPS estimates for the upcoming year range from $6.40 to $7.90, with 39 analysts involved in the forecasting process.
Overall, it appears that analysts are generally optimistic about the company's future earnings per share, with gradual increases expected in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the historical performance. However, the company is still projected to experience double-digit growth over the next 5 years according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $200. However, there is a wide range of estimates, from a low of $164 to a high of $250. The current price of the security is below both the average and median forecast, suggesting that there may be potential for growth according to the analysts' predictions.
MACD of PLPL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
